Home > Publications database > A new IDH-independent hypermethylation phenotype is associated with astrocyte-like cell state in glioblastoma. > print |
001 | 302878 | ||
005 | 20250718114120.0 | ||
024 | 7 | _ | |a 10.1186/s13059-025-03670-y |2 doi |
024 | 7 | _ | |a pmid:40611337 |2 pmid |
024 | 7 | _ | |a pmc:PMC12225510 |2 pmc |
024 | 7 | _ | |a 1465-6906 |2 ISSN |
024 | 7 | _ | |a 1465-6914 |2 ISSN |
024 | 7 | _ | |a 1474-7596 |2 ISSN |
024 | 7 | _ | |a 1474-760X |2 ISSN |
037 | _ | _ | |a DKFZ-2025-01418 |
041 | _ | _ | |a English |
082 | _ | _ | |a 570 |
100 | 1 | _ | |a Costa, Ana Luisa |b 0 |
245 | _ | _ | |a A new IDH-independent hypermethylation phenotype is associated with astrocyte-like cell state in glioblastoma. |
260 | _ | _ | |a London |c 2025 |b BioMed Central |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1752751081_14020 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a DNA methylation plays a crucial role in cancer development and progression and has been linked to genetically and clinically distinct tumor classes, including IDH-mutated and IDH-wildtype adult-type diffuse gliomas. Here, we identify a CpG-island methylator phenotype (CIMP) that characterizes the receptor tyrosine kinase 2 (RTK2) subtype of IDH-wildtype glioblastoma.This RTK2-CIMP affects genomic locations and cell functions distinct from those of IDH mutation-associated IDH-CIMP and suppresses the expression of its target genes. The RTK2-CIMP-region chromatin is characterized by a combination of repressive and activating marks, including polycomb-associated H3K27me3 and enhancer-associated H3K4me1, consistent with DNA methylation-mediated silencing of genes with bivalent-state promoters in neural progenitor cells. Functionally, RTK2-CIMP affects neuronal lineage genes and is significantly associated with astrocyte-like glioblastoma, suggesting that RTK2-CIMP is an epigenetic signature of the astrocyte-like cell state. Furthermore, we demonstrate that RTK2-CIMP can be induced by genetic manipulation in glioblastoma cells.Our results suggest that RTK2-CIMP is a key contributor to cell-state plasticity in glioblastoma. |
536 | _ | _ | |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312) |0 G:(DE-HGF)POF4-312 |c POF4-312 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
650 | _ | 7 | |a Isocitrate Dehydrogenase |0 EC 1.1.1.41 |2 NLM Chemicals |
650 | _ | 2 | |a Glioblastoma: genetics |2 MeSH |
650 | _ | 2 | |a Glioblastoma: pathology |2 MeSH |
650 | _ | 2 | |a Glioblastoma: metabolism |2 MeSH |
650 | _ | 2 | |a Humans |2 MeSH |
650 | _ | 2 | |a DNA Methylation |2 MeSH |
650 | _ | 2 | |a Isocitrate Dehydrogenase: genetics |2 MeSH |
650 | _ | 2 | |a Isocitrate Dehydrogenase: metabolism |2 MeSH |
650 | _ | 2 | |a Astrocytes: metabolism |2 MeSH |
650 | _ | 2 | |a Astrocytes: pathology |2 MeSH |
650 | _ | 2 | |a Phenotype |2 MeSH |
650 | _ | 2 | |a Cell Line, Tumor |2 MeSH |
650 | _ | 2 | |a CpG Islands |2 MeSH |
650 | _ | 2 | |a Epigenesis, Genetic |2 MeSH |
650 | _ | 2 | |a Gene Expression Regulation, Neoplastic |2 MeSH |
650 | _ | 2 | |a Brain Neoplasms: genetics |2 MeSH |
650 | _ | 2 | |a Brain Neoplasms: pathology |2 MeSH |
700 | 1 | _ | |a Doncevic, Daria |b 1 |
700 | 1 | _ | |a Wu, Yonghe |0 P:(DE-He78)048cd293ec9a8bd9be8a97dde02ee343 |b 2 |
700 | 1 | _ | |a Yang, Lin |b 3 |
700 | 1 | _ | |a Man, Ka Hou |0 P:(DE-He78)54ffbd220f4f40801144e564197dd3d4 |b 4 |
700 | 1 | _ | |a Spreng, Anna-Sophie |0 P:(DE-He78)c4c258d44a86b1ab0d1c5d7370a4a916 |b 5 |u dkfz |
700 | 1 | _ | |a Winter, Hannah |b 6 |
700 | 1 | _ | |a Fletcher, Michael |0 P:(DE-He78)531cf6e04ba45b3c088cd4d4d3cc3c36 |b 7 |
700 | 1 | _ | |a Radlwimmer, Bernhard |0 P:(DE-He78)d1939d434dd885fad08106329e3db719 |b 8 |u dkfz |
700 | 1 | _ | |a Herrmann, Carl |b 9 |
773 | _ | _ | |a 10.1186/s13059-025-03670-y |g Vol. 26, no. 1, p. 192 |0 PERI:(DE-600)2040529-7 |n 1 |p 192 |t Genome biology |v 26 |y 2025 |x 1465-6906 |
909 | C | O | |o oai:inrepo02.dkfz.de:302878 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)048cd293ec9a8bd9be8a97dde02ee343 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)54ffbd220f4f40801144e564197dd3d4 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)c4c258d44a86b1ab0d1c5d7370a4a916 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)531cf6e04ba45b3c088cd4d4d3cc3c36 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)d1939d434dd885fad08106329e3db719 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-312 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Funktionelle und strukturelle Genomforschung |x 0 |
914 | 1 | _ | |y 2025 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-20 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-20 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b GENOME BIOL : 2022 |d 2024-12-20 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-05-02T09:06:40Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-05-02T09:06:40Z |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2023-05-02T09:06:40Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-20 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |d 2024-12-20 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2024-12-20 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-20 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2024-12-20 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2024-12-20 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-20 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-20 |
915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b GENOME BIOL : 2022 |d 2024-12-20 |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2024-12-20 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2024-12-20 |
920 | 1 | _ | |0 I:(DE-He78)B060-20160331 |k B060 |l B060 Molekulare Genetik |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)B060-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|